Hepatocellular carcinoma (HCC)
Hepatocellular carcinoma (HCC) is cancer that starts in the liver, it is not the same as metastatic liver cancer, which starts in another organ (such as the breast or colon) and spreads to the liver.
Practice Guidelines: Management of hepatocellular carcinoma
Journal of Hepatology
July 2018 Volume 69, Issue 1, Pages 182–236
Risk factors including viral hepatitis (hepatitis C, hepatitis B infection), alcoholic liver disease, and NASH from the metabolic syndrome—I think all of those can cause chronic inflammation, eventually leading to cirrhosis, which increases the risk of having HCC develop in the liver.
Recognizing Hepatocellular Carcinoma (HCC) Risk Factors
View a series of videos and articles about liver cancer available at OncLive:
Steady Increase in Liver Cancer Death Rates Observed in Adults ...
OncLive
A National Center for Health Statistics (NCHS) briefing stratifies liver cancer mortality by sex, ethnicity, and age for adults aged 25 years and …
Diabetes drug may prevent liver cancer
by Liz Entman Sep. 21, 2018, 9:05 AM
A drug commonly used to treat type 2 diabetes might help prevent patients from developing liver cancers. In a study published this month in the journal Cancer Causes & Control, Harvey J. Murff, MD, MPH, and colleagues found that patients taking metformin had a reduced rate of liver cancer compared to patients taking an alternative anti-diabetes drug.
Diabetes drug may prevent liver cancer
by Liz Entman Sep. 21, 2018, 9:05 AM
A drug commonly used to treat type 2 diabetes might help prevent patients from developing liver cancers. In a study published this month in the journal Cancer Causes & Control, Harvey J. Murff, MD, MPH, and colleagues found that patients taking metformin had a reduced rate of liver cancer compared to patients taking an alternative anti-diabetes drug.
(Reuters Health) - People with advanced cases of nonalcoholic fatty liver disease (NAFLD) may need to be watched for liver cancer, a large …
No comments:
Post a Comment